Table 2.
Epigenetic Changes | Involved Gene | Involved Protein | Role of the Protein | Results |
---|---|---|---|---|
DNA methylation of CpG, leading to loss of function | CDH1 gene promoter (E-cadherin gene promoter) | E-cadherin | Intercellular adhesion molecule | Hypermethylation of this gene is more frequent in invasive forms of SCC compared to AK and normal population. Hypermethylation of CDH1 gene promoter is present in 95% of cutaneous squamous cell carcinoma samples [63,64]. |
DNA methylation of CpG, leading to loss of function | CDH13 gene promoter (T-cadherin gene promoter) | T-cadherin | Cell migration; Phenotypic changes; Calcium ion transport |
Hypermethylation of T-cadherin gene promoter is associated with phenotypic cellular changes, both in SCC and in actinic keratoses that will evolve into invasive SCC [65,66]. |
DNA methylation of CpG, leading to loss of function | CDKN2A gene | p16 (ARF) | Tumor suppressor genes—cell cycle regulator proteins | Hypermethylation is associated with a statistically significant decrease in the synthesis of aforementioned proteins (identified by immunohistochemical studies) (p < 0.001), with the inactivation of p16 and p14 [64]. |
DNA methylation of CpG, leading to loss of function | CDKN2A gene | p14 (INK4A) | ||
DNA methylation of CpG, leading to loss of function | Retinoblastoma protein 1 (RB1) gene | RB1 | ||
DNA methylation of CpG, leading to loss of function | SFRP1-5 promoter gene | SFRP1-5 glycoproteins | Modulatory effects on Wnt pathway | Hypermethylation of the promoter region of these genes leads to a decrease in the expression of SFRP1-5 proteins in cSCC. It can be used as a marker of cSCC [67]. |
DNA methylation of CpG, leading to loss of function | FRZB (frizzled-related protein) promoter gene | FRZB protein | Modulatory effects on Wnt pathway—involved in cell growth and differentiation | Hypermethylation of the promoter of this gene is significantly higher in metastatic cSCC compared to non-metastatic forms (p = 0.00004). It can be used as a marker of subtypes with aggressive evolution [68]. |
DNA methylation of CpG, leading to loss of function | Death-associated protein kinase 1 (DAPK1) gene | DAPK1 | Tumor suppressor activity—protein involved in apoptosis and autophagy | DAPK1 hypermethylation is much more frequent in invasive forms of cSCC [66]. |